Johnson & Johnson’s second-quarter earnings fell almost 5%, but profit and revenue beat analyst forecasts helped by surprisingly resilient pharmaceutical and consumer product sales.
*For more on this story,
read the full Reuters
article.
Johnson & Johnson’s second-quarter earnings fell almost 5%, but profit and revenue beat analyst forecasts helped by surprisingly resilient pharmaceutical and consumer product sales.
*For more on this story,
read the full Reuters
article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99